drugset
drugset / Trial / NCT01620450

Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process in Healthy Japanese

NCT01620450 ↗

Phase 1 Completed 34 enrolled Novo Nordisk A/S
RandomizedCrossoverDouble-blindTreatment

Summary

This trial is conducted in Japan. The aim of this trial is to compare insulin aspart produced by current process and the NN2000 process in healthy Japanese subjects.

Timeline

Start
2004-11-20
Primary completion
2005-02-26
Completion
2005-02-26

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin aspart Protein / enzyme biologic — Subcutaneous

Indications

diabetes mellitus